Your email has been successfully added to our mailing list.

×
0 0 0.00140845070422532 0.00845070422535206 -0.00281690140845077 -0.00140845070422532 -0.0126760563380281 -0.0126760563380281
Stock impact report

FDA OKs Chembio's Ebola test [Seeking Alpha]

Chembio Diagnostics, Inc. (CEMI) 
Last chembio diagnostics, inc. earnings: 3/12 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: chembio.com/investors/investor-relations
Company Research Source: Seeking Alpha
FDA OKs Chembio's Ebola testThe FDAgrants emergency use authorization (EUA) for Chembio Diagnostics' (CEMI-1.7%) DPP Ebola Antigen System, a rapid single-use finger-stick test for the detection of the Ebola virus.The agency says this the EUA is the ninth for nucleic acid tests and the second for rapid diagnostic tests for Ebola virus detection.Click to subscribe to real-time analytics on CEMINow read:Novelion Therapeutics leads healthcare gainers; Omeros and ViewRay among losers »Subscribefor full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
CEMI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CEMI alerts
Opt-in for
CEMI alerts

from News Quantified
Opt-in for
CEMI alerts

from News Quantified